Radiation Field
Showing 1 - 25 of >10,000
Radiation Field, Dose and Fractionation Related to Mandibular
Recruiting
- Head and Neck Neoplasms
- +2 more
- Radiotherapy
-
Lund, SwedenSkane University Hospital
Jun 7, 2022
Dermatitis, Radiation Induced Trial in Giza (Pulsed electromagnetic field, traditional skin care)
Not yet recruiting
- Dermatitis, Radiation Induced
- Pulsed electromagnetic field
- traditional skin care
-
Giza, Egyptahram canadian University
Aug 18, 2023
During MR-guided Radiation Therapy for Glioblastoma
Recruiting
- Glioblastoma Multiforme
- Low field (0.35 T) MR-images of the brain at a MRIdian® linac system
-
Zürich, Zurich, SwitzerlandUniversity Hospital Zurich
Sep 29, 2022
Head Neck Cancer, Carcinoma, Squamous Cell, Tumors, Oral Trial in Chicago, Dallas (Intensity Modulated Radiation Therapy, chemo)
Completed
- Head and Neck Cancer
- +3 more
- Intensity Modulated Radiation Therapy
- chemotherapy
-
Chicago, Illinois
- +1 more
Feb 16, 2022
Malignant Solid Tumor, Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Non-Small Cell Cancer AJCC v7 Trial in Houston
Active, not recruiting
- Malignant Solid Neoplasm
- +2 more
- 3-Dimensional Conformal Radiation Therapy
- +6 more
-
Houston, TexasM D Anderson Cancer Center
Jul 18, 2022
Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8, Stage IIIB Prostate Cancer AJCC v8 Trial in Atlanta
Recruiting
- Stage III Prostate Cancer AJCC v8
- +3 more
- High-Dose Rate Brachytherapy
- +3 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Jul 8, 2022
Leptomeningeal Metastases Trial in United States (Involved-field Photon Radiation Therapy, Proton Craniospinal Irradiation
Active, not recruiting
- Leptomeningeal Metastases
- Involved-field Photon Radiation Therapy
- +3 more
-
Basking Ridge, New Jersey
- +7 more
Jul 22, 2022
Brain Metastases Trial in Changsha (ASCLU-300 TTF)
Recruiting
- Brain Metastases
- ASCLU-300 TTF
-
Changsha, Hunan, ChinaXiangya Hospital Central South University
Feb 27, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Melanoma of Unknown Primary, Metastatic Malignant Tumor in the Brain Trial in
Recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +6 more
- Ipilimumab
- +4 more
-
Atlanta, GeorgiaEmory University Hospital/Winship Cancer Institute
Dec 12, 2022
Lymphoma, Extranodal NK-T-Cell Trial in Shanghai (Pembrolizumab, Involved Field Radiation Therapy)
Recruiting
- Lymphoma, Extranodal NK-T-Cell
- Pembrolizumab
- Involved Field Radiation Therapy
-
Shanghai, ChinaShanghai Rui-Jin Hospital
Mar 29, 2022
Glioblastoma Trial in Philadelphia (drug, radiation, device, procedure)
Recruiting
- Glioblastoma
- Temozolomide
- +3 more
-
Philadelphia, PennsylvaniaSidney Kimmel Cancer Center at Thomas Jefferson University
Jun 3, 2021
Leukemia Trial in Duarte (drug, procedure, radiation)
Active, not recruiting
- Leukemia
- cyclophosphamide
- +6 more
-
Duarte, CaliforniaCity of Hope Medical Center
Mar 17, 2022
Effect of FOV and mA on Metal Artifacts on CBCT
Recruiting
- Metal Artifacts
- Implant
- CBCT radiation
-
Cairo, Giza, EgyptRoshan Adel
Oct 13, 2021
Hodgkin Lymphoma Trial in Italy, United States (Rituximab, Involved field irradiation)
Terminated
- Hodgkin Lymphoma
- Rituximab
- Involved field irradiation
-
Houston, Texas
- +10 more
Aug 18, 2021
Pancreatic Adenocarcinoma, Stage IA Pancreatic Cancer, Stage IB Pancreatic Cancer Trial in Richmond (drug, radiation, other)
Active, not recruiting
- Pancreatic Adenocarcinoma
- +6 more
- Gemcitabine
- +6 more
-
Richmond, VirginiaVirginia Commonwealth University/Massey Cancer Center
Oct 20, 2021
Glioblastoma, Glioblastoma Multiforme, Glioma Trial in Los Angeles (Dendritic cell vaccination, in addition to standard
Completed
- Glioblastoma
- +4 more
- Dendritic cell vaccination, in addition to standard temozolomide chemotherapy and involved field radiation therapy
- Dendritic cell vaccination, with optional bevacizumab treatment for patients previously treated with bevacizumab
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
Nov 18, 2021
Breast Cancer Trial in Seoul (Virtual reality)
Recruiting
- Breast Cancer
- Virtual reality
-
Seoul, Korea, Korea, Republic ofSeverance Hospital
Nov 16, 2020
Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2
Active, not recruiting
- Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
- +22 more
- External Beam Radiation Therapy
- Orbital Radiation
-
Houston, TexasM D Anderson Cancer Center
Dec 9, 2022
Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Tremelimumab, Yttrium-90 radioembolisation)
Recruiting
- Hepatocellular Carcinoma
- Durvalumab
- +2 more
-
Hong Kong, Hong KongDepartment of Clinical Oncology, Queen Mary Hospital
Apr 10, 2023
Recurrent Mantle Cell Lymphoma, Refractory Mantle Cell Lymphoma Trial in Houston (Low Dose Radiation Therapy)
Recruiting
- Recurrent Mantle Cell Lymphoma
- Refractory Mantle Cell Lymphoma
- Low Dose Radiation Therapy
-
Houston, TexasM D Anderson Cancer Center
Jan 30, 2023
Blister Fluid in Healthy Volunteers and Irradiated Skin
Completed
- Breast Cancer
- +2 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Recurrent Gynecological Cancer, Metastatic Cervical Cancer, Metastatic Ovarian Cancer Trial in Boston (Durvalumab, Tremelimumab,
Terminated
- Recurrent Gynecological Cancer
- +10 more
- Durvalumab
- +2 more
-
Boston, MassachusettsMartin King
Oct 4, 2022
DLBCL - Diffuse Large B Cell Lymphoma, High-grade B-cell Lymphoma, Follicular Lymphoma Trial (Bridging radiation therapy,
Not yet recruiting
- DLBCL - Diffuse Large B Cell Lymphoma
- +6 more
- Bridging radiation therapy
- +2 more
- (no location specified)
Jan 4, 2023
Resectable Soft Tissue Sarcoma, Stage I Soft Tissue Sarcoma of the Trunk and Extremities AJCC v8, Stage IA Soft Tissue Sarcoma
Active, not recruiting
- Resectable Soft Tissue Sarcoma
- +7 more
- Hypofractionated Radiation Therapy
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Aug 22, 2022